Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
24 hedge funds and large institutions have $17.5M invested in Marrone Bio Innovations, Inc. in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
4% more funds holding
Funds holding: 23 → 24 (+1)
10% less capital invested
Capital invested by funds: $19.5M → $17.5M (-$1.99M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.8K |
| 3 |
BlackRock
New York
|
+$14K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.24K |
| 5 |
AWS
AJ Wealth Strategies
New York
|
+$6.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$261K |
| 2 |
SIM
Spark Investment Management
New York
|
-$39K |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$23.9K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$19.2K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$7K |
MBII Hedge Fund Activity: Q1 2017 in Review
24 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2017, worth a combined $17.5M — down 10% from $19.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MBII positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $26.4K. The largest seller was Primecap Management, cutting an estimated $261K.
- 24 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2017, up from 23 in Q4 2016.
- Funds reported $17.5M of Marrone Bio Innovations, Inc. stock for Q1 2017, down 10% quarter-over-quarter.
- 4 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2017 and 2 closed out, a net change of +2 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2017 was Citadel Advisors, an estimated $26.4K added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2017 was Primecap Management, an estimated $261K sold.
Based on aggregated 13F filings for Q1 2017.